drugset / Trial / NCT00014911

Islet Transplantation for Type 1 Diabetes

NCT00014911

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to test whether the islet cell transplantation procedures and results from a previous study in Edmonton, Canada, can be repeated. The study also is designed to learn more about diabetes control using islet cell transplantation. This is a Phase I/II study (a study that examines effectiveness and looks for side effects). The transplanting of islet cells has been studied in Type 1 diabetic patients whose blood sugar levels will not stay normal, despite intensive insulin therapy. A recent study conducted in Edmonton, Canada, was able to demonstrate that islet transplantation led to insulin independence in a majority of the patients treated. This study extends the results obtained from the Edmonton study, which used islet transplantation in Type 1 diabetic patients with steroid-free immunosuppression.

Timeline

Start
2001-04
Primary completion
2005-06
Completion
2010-08

Drugs

EvaluationDrugModalityDoseRoute
Background Daclizumab Monoclonal antibody 1 mg/kg Intravenous
Background Ganciclovir Small molecule
Background Pentamidine Unknown
Background Sirolimus Small molecule 0.1 mg/kg Oral
Background Sulfamethoxazole Small molecule
Background Tacrolimus Small molecule 1 mg Oral
Background Trimethoprim Small molecule